September 2011

26 September 2011
The ETICS project, led by CYTOO in collaboration with Cellectis bioresearch and the CEA, to receive €7.6 million in aid from OSEO. A collaboration to develop highly innovative kits for pharmaceutical research Paris, September 26, 2011 - CYTOO, a company that specializes in cell-based assays (Grenoble, France), has joined up with Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), and the CEA, the French Alternative Energies and Atomic Energy Commission, to develop new high-value cell-based assays for drug development and...